| Literature DB >> 12414784 |
Arnon P Kater1, Maikel P Peppelenbosch, Dees P M Brandjes, Mika Lumbantobing.
Abstract
Warfarin, a widely prescribed drug for preventing thrombosis, is thought to act solely through inhibition of vitamin K-dependent coagulation factors. Low concentrations of warfarin inhibit interleukin-6 production and phosphorylation of I-kappa B but not activation of p38 mitogen-activated protein kinase. Thus, warfarin inhibits inflammatory signal transduction, and this may contribute to clinical effects of warfarin.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12414784 PMCID: PMC130100 DOI: 10.1128/cdli.9.6.1396-1397.2002
Source DB: PubMed Journal: Clin Diagn Lab Immunol ISSN: 1071-412X